President Trump has canceled an FDA contract to purchase body parts of aborted babies for use in research experiments after being alerted to the shocking new contract with a company that deals in baby parts and has clients including Planned Parenthood.
Pro-life Americans disturbed by the news that the taxpayer funded FDA had entered the baby body parts market made their concerns known to President Trump, and late Monday the Health and Human Services department (HHS) announced it had canceled the contract with Advanced Bioscience Resources because it didn’t include “appropriate protections” regarding fetal tissue procurement.
As reported in August, shocking revelations indicated the Food and Drug Administration signed a new contract to acquire body parts from aborted babies to be transplanted into so-called “humanized mice.”
BYPASS THE CENSORS
Sign up to get unfiltered news delivered straight to your inbox.
The grisly experiments allow mice to have a functioning human immune system for research purposes.
The Health and Human Services department (HHS) is now under orders to review alternatives to the use of human fetal tissue in taxpayer funded research.
The agency said in a statement that it has “initiated a comprehensive review of all research involving fetal tissue to ensure consistency with statutes and regulations governing such research.”
The full statement reads:
“After a recent review of a contract between Advanced Bioscience Resources, Inc. and the Food and Drug Administration to provide human fetal tissue to develop testing protocols, HHS was not sufficiently assured that the contract included the appropriate protections applicable to fetal tissue research or met all other procurement requirements. As a result, that contract has been terminated, and HHS is now conducting an audit of all acquisitions involving human fetal tissue to ensure conformity with procurement and human fetal tissue research laws and regulations. In addition, HHS has initiated a comprehensive review of all research involving fetal tissue to ensure consistency with statutes and regulations governing such research, and to ensure the adequacy of procedures and oversight of this research in light of the serious regulatory, moral, and ethical considerations involved. Finally, HHS is continuing to review whether adequate alternatives exist to the use of human fetal tissue in HHS funded research and will ensure that efforts to develop such alternatives are funded and accelerated.”
LifeSiteNews reports: One pro-life group said more protections are needed to ensure the FDA and HHS do not sign other agreements to purchase aborted baby parts in the future.
“Canceling a single contract and conducting a review is a small step forward, but overall is completely inadequate,” said Susan B. Anthony List president Marjorie Dannenfelser in a statement.
The department appears to be moving in that direction. HHS is also conducting an audit of all acquisitions involving human fetal tissue to “ensure conformity with procurement and human fetal tissue research laws and regulations,” the statement says.
The agency also said it would continue reviewing alternatives to human fetal tissue in HHS funded research “and will ensure that efforts to develop such alternatives are funded and accelerated.”
Earlier, some 48 national and state pro-life leaders urged HHS to end the government’s use of aborted fetal tissue for research and turn to ethical alternatives.
The letter reads, in part:
“We were shocked and dismayed at the news report that the Food and Drug Administration (FDA) has signed a contract to purchase ‘fresh’ aborted fetal organs from Advanced Bioscience Resources, for the purpose of creating humanized mice with human immune systems. We expect far better of our federal agencies – especially under the leadership of a courageous pro-life president – entrusted with the health of American citizens. It is completely unacceptable to discover that the FDA is using federal tax dollars and fomenting demand for human body parts taken from babies who are aborted. …The federal government must find ethical alternatives as soon as possible, and should end all association with those who participate in any trafficking or procurement of aborted baby organs. No taxpayer dollars should continue to go to this gruesome practice.”
In August, CNSNews reported the details of the new FDA contracts, signed on July 25, according to information published by the FDA and the General Services Administration:
“The objective is to acquire Tissue for Humanized Mice,” said a June 13 FDA “presolicitation notice” for the contract.
The contractor, the notice said, would “provide the human fetal tissue needed to continue the ongoing research being led by FDA.
“Fresh human tissues are required,” said the notice, “for implantation into severely immune-compromised mice to create chimeric animals that have a human immune system.”
According to GSA’s federal contract database, Advanced Bioscience Resources (ABR), a non-profit organization based in the San Francisco Bay Area, was awarded this $15,900 contract, which will run through July 25, 2019.
“Fetal tissue used in research is obtained from elective abortions,” says the Congressional Research Service.
As CNS reported, the FDA is using federal tax dollars to create a demand for human body parts that must be taken from babies who are aborted.
Because it would not be able to create its “humanized mice” without fresh tissue taken from aborted babies, the FDA also has an interest in the continuation of legalized abortions at a stage in fetal development when the tissue needed to create these mice can be retrieved from the aborted baby.
While the FDA confirmed to CNSNews.com that its June 13 presolicitation notice for a contract to “acquire Tissue for Humanized Mice” and the July 25 contract it signed with ABR (as reported on the GSA contract database) refer to the same deal, the FDA declined to answer 17 other questions CNSNews.com asked it about that contract and the aborted baby parts it requires the contractor to provide. (See the full set of questions CNSNews.com sent to the FDA by clicking here.)
Instead the FDA provided CNSNews.com with a three-paragraph statement. (See the FDA’s full statement by clicking here.)
In its statement to CNSNews.com, the FDA stressed that it was committed to making certain its research followed “all legal requirements” and met “the highest ethical standards.”
Apart from the destruction of human life and the exploitation of aborted babies by using their body parts for research, the pro-life movement has long questioned the ethics of transplanting human brains cells into other species.
When Planned Parenthood was exposed selling aborted baby parts for such research, videos recorded a conversation between Melissa Farrell, Director of Research for Planned Parenthood Gulf Coast, and two CMP actors posing as representatives of an organ procurement company. That conversation focused on potential compensation to Planned Parenthood in exchange for fetal remains.
Farrell made it clear that Planned Parenthood had been involved in the selling of aborted baby parts for some time and was very familiar with the use of fetal remains in the production of humanized mice.
Latest posts by Baxter Dmitry (see all)
- FBI Says They Cannot Guarantee Their Biden Bribery Scheme Informant Will Not Be Killed - June 6, 2023
- WEF Insider Brags ‘False Flag’ on Power Grid Will Result in Holocaust of Non-Compliant Humans - June 4, 2023
- The Atlantic Magazine Declares the World Would Be ‘Sterile and Boring’ Without Pedophiles - June 4, 2023